z-logo
Premium
Psychometric re‐evaluation of the immunosuppressant therapy adherence scale among solid‐organ transplant recipients
Author(s) -
Wilks Scott E.,
Spivey Christina A.,
ChisholmBurns Marie A.
Publication year - 2010
Publication title -
journal of evaluation in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.737
H-Index - 73
eISSN - 1365-2753
pISSN - 1356-1294
DOI - 10.1111/j.1365-2753.2008.01115.x
Subject(s) - cronbach's alpha , medicine , scale (ratio) , clinical psychology , construct validity , physical therapy , psychometrics , physics , quantum mechanics
Rationale  The objective of this study was to conduct a psychometric re‐evaluation of the immunosuppressant therapy adherence scale (ITAS), a self‐report measure of immunosuppressant therapy (IST) adherence targeted to solid‐organ transplant recipients. Methods  Mailed questionnaires were used to collect data from 141 transplant recipients. A factor analysis of the ITAS was conducted. Validity was examined via Pearson's product‐moment correlations ( r ) to theoretically tied measures of social support and resilience. Cronbach's and split‐half alpha coefficients determined internal consistency. Results  The response rate was 72.3%. The aggregate mean on ITAS' summed scores was 11.0 (standard deviation = 1.7). The single IST adherence factor had an eigenvalue of 2.92 and accounted for 73% of the scale items' variance. Component loadings for ITAS items were high (≥0.80). Zero‐order correlations among scale items were moderately strong (≥0.57) and significant ( P  < 0.01). ITAS summed scores were significantly associated with measures of social support and resilience ( r  ≥ 0.20, P  < 0.05). Cronbach's alpha was 0.87. The Guttman split‐half coefficient was 0.90. Conclusions  This re‐evaluation provides needed confirmation that the ITAS is a valid and reliable measure of IST adherence. The ITAS may be useful as an IST adherence measure in the outpatient transplant clinic setting as it is easy to administer, brief and less expensive than many other adherence measures.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here